Anna Frostegård, MD, PhD
Annexin Pharmaceuticals AB
1
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Pablo Velazquez-Martin, MD
Kodiak Sciences Inc
Shared therapeutic areas:
Iwar Klimes, Prof., MD, DrSc.
Novartis Slovakia, s.r.o.
Shared therapeutic areas:
Virgilio Lima Gomez, MD, MsC
Hospital Juarez de Mexico
Shared therapeutic areas:
Xiaorong Li, professor
Tianjin Medical University Eye Hospital
Shared therapeutic areas:
Ivana Hojsikova, RNDr.
Medirex Group Academy
Shared therapeutic areas:
xiangmei chen
Chinese PLA General Hospital
Shared therapeutic areas:
Gerhard Garhöfer, MD
Department of Clinical Pharmacology, Medical University of Vienna
Shared therapeutic areas:
Francisco Garcia-Rio, MD
Hospital Universitario La Paz, IdiPAZ
Shared therapeutic areas:
Marta Ondrejkova, MD PhD.
F.D. Roosevelt Hospital Banska Bystrica
Shared therapeutic areas:
Emil Martinka, MD, PhD.
National Institute for Endocrinology and Diabetology
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion
All 1 trials loaded